Stocks Under $10
Inovio Rises On Phase 1 Data for Zika Vaccine -- Biotech Movers
The Plymouth Meeting, Pa.-based firm said a Phase 1 study of Zika vaccine GLS-5700 'induced high levels of binding antibodies in 100% of participants.'
Biotech Mailbag: Buy Dip in T2 Biosystems?
Plus, what's going on with Lexicon Pharmaceuticals?
Fresh Volatility Warrants Caution
The slowest part of the trading year is setting up for the most volatile month.
Sticking to Our Guns on Gastar
The energy company takes a hit after earnings, but there's still reason for optimism.
Stocks Under $10 Portfolio: Not Resting on Our Laurels
The portfolio has outperformed the Russell 2000 index by more than 400 basis points, year to date.
Good 'Net/Net' Stocks Are Hard to Find
Just five non-biotech names trade below net current asset value.
TG Therapeutics Looks Like a Healthy Play
Small biotech tanked on weak earnings, but still seems promising.
Synergy Pharma Offers Lots of Synergies
I expect Allergan or another player to bid for SGYP soon.
Everybody's Doing It: 5 Stocks Under $10 That I Like
These have positive momentum and good growth.
Homebuilders Back in Play for 2014
The continued growth in housing starts is a good sign for homebuilders in the new year, says Stocks Under $10 Portfolio Manager David Peltier.